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Abstract
Background: Subsequent epidemic waves have already emerged in many countries and in the absence of highly
effective preventive and curative options, the role of patient characteristics on the development of outcomes needs
to be thoroughly examined, especially in middle-east countries where such epidemiological studies are lacking. There
is a huge pressure on the hospital services and in particular, on the Intensive Care Units (ICU). Describing the need for
critical care as well as the chance of being discharged from hospital according to patient characteristics, is essential for
a more efficient hospital management. The objective of this study is to describe the probabilities of admission to the
ICU and the probabilities of hospital discharge among positive COVID-19 patients according to demographics and
comorbidities recorded at hospital admission.
Methods: A prospective cohort study of all patients with COVID-19 found in the Electronic Medical Records of Jaber
Al-Ahmad Al-Sabah Hospital in Kuwait was conducted. The study included 3995 individuals (symptomatic and
asymptomatic) of all ages who tested positive from February 24th to May 27th, 2020, out of which 315 were treated in
the ICU and 3619 were discharged including those who were transferred to a different healthcare unit without having
previously entered the ICU. A competing risk analysis considering two events, namely, ICU admission and hospital
discharge using flexible hazard models was performed to describe the association between event-specific
probabilities and patient characteristics.
Results: Results showed that being male, increasing age and comorbidities such as chronic kidney disease (CKD),
asthma or chronic obstructive pulmonary disease and weakened immune system increased the risk of ICU admission
within 10 days of entering the hospital. CKD and weakened immune system decreased the probabilities of discharge
in both females and males however, the age-related pattern differed by gender. Diabetes, which was the most
prevalent comorbid condition, had only a moderate impact on both probabilities (18% overall) in contrast to
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CKD which had the largest effect, but presented only in 7% of those admitted to ICU and in 1% of those who got
discharged. For instance, within 5 days a 50-year-old male had 19% (95% C.I.: [15,23]) probability of entering the ICU if
he had none of these comorbidities, yet this risk jumped to 31% (95% C.I.: [20,46]) if he had also CKD, and to 27% in the
presence of asthma/COPD (95% C.I.: [19,36]) or of weakened immune system (95% C.I.: [16,42]).
Conclusions: This study provides useful insight in describing the probabilities of ICU admission and hospital
discharge according to age, gender, and comorbidities among confirmed COVID-19 cases in Kuwait. A web-tool is
also provided to allow the user to estimate these probabilities for any combination of these covariates. These
probabilities enable deeper understanding of the hospital demand according to patient characteristics which is
essential to hospital management and useful for developing a vaccination strategy.
Keywords: Competing risks, COVID-19, Probability of ICU admission
Introduction
A cluster of pneumonia cases was reported in Wuhan,
China, in the last weeks of 2019 [1]. The virus responsi-
ble for this ensemble of symptoms, subsequently named
COVID-19 [2, 3], was quickly identified, sequenced
and called the Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-COV-2) [4]. The responsible virus
was characterised as easily contagious and soon the epi-
demic quickly spread first within China and then across
the rest of the world. The World Health Organization
(WHO) declared that the outbreak was of international
concern at the end of January 2020 and announced the
pandemic in March 2020 [5]. Soon it became apparent
that the virus could cause severe forms of the disease,
sometimes lethal, in particular for individuals of older ages
or with comorbid conditions [3]. Given these character-
istics, the human cost of this pandemic has continued to
mount with to date over 60 million cases and 1.4 million
deaths from COVID-19 [6].
The onset of COVID-19 outbreak in the Gulf Cooper-
ation Council (GCC) countries was evidenced between
February 2020-March 2020 [7, 8]. At the end of January,
the first known incident case of COVID-19 in GCC was
reported by the United Arab Emirates, soon followed by
early COVID-19 case reports made by Bahrain, Kuwait,
Qatar, and Oman in late February 2020 [8]. The govern-
ment of the state of Kuwait instructed the repatriation of
all their citizens and relatives just before the surge of cases
in Iran [9].
Worldwide, lockdown policies have been applied to
most countries in an effort to mitigate the widespread of
the virus, flatten the epidemic curve, and reduce the bur-
den of the pandemic on the health system [3]. Kuwait
in particular, promptly applied aggressive controls to sur-
round and contain the disease; all international flights
from Kuwait airport were suspended, land borders with
neighbouring countries were closed, as well as, schools,
universities, governmental offices and businesses were
shut [8, 10]. These measures were accompanied by a
partial curfew and further restrictions on geographical
areas of high-risk of community transmission [10]. Other
strict measures were also enforced in order to contain the
pathogen from spreading, including the use of the reverse
transcriptase-polymerase chain reaction (RT-PCR) test
for all arrivals and their extended families along with the
susceptible individuals who came in contact with con-
firmed COVID-19 cases [9]. The screening also covered
high-risk residential areas including those with large num-
ber of migrant workers who are living in big households
within a minimal space [9, 11]. Furthermore, from the
24th of February 2020 until the 12th of May 2020, all
known cases, symptomatic or asymptomatic, were sent
to a single designated COVID-19 centre, the Jaber Al-
Ahmad Al-Sabah hospital. As such, Jaber hospital was
used both as a quarantine and treatment facility by the
Government of Kuwait during that period, and solely as a
treatment centre afterwards.
Subsequent epidemic waves have already emerged in
many countries and in the absence of highly effective pre-
ventive and curative options, there is a need for detailed
epidemiological examination of the role of patients char-
acteristics on the development of outcomes. Here, we aim
to describe how the patients characteristics (demograph-
ics and comorbidities) are associated with the probabili-
ties of admission to an Intensive Care Unit (ICU) and the
probabilities of hospital discharge among the cohort of
patients admitted into Jaber Hospital in Kuwait.
Methods
Study design and patient recruitment
This is a prospective cohort study including all confirmed
COVID-19 cases in Kuwait admitted to Jaber Hospital
between 24 of February 2020 and 27 of May 2020. All
these cases, either symptomatic or asymptomatic, were
confirmed COVID-19 cases, based on a real-time reverse-
transcriptase-polymerase chain-reaction (RT-PCR) assay
of nasopharyngeal swab specimens. Patients with equivo-
cal or negative results were excluded from the analysis.
Data on all confirmed COVID-19 cases, extracted from
Electronic Medical Records (EMR) of Jaber Hospital,
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contained information on their demographic (age, sex,
and residency) and anthropometric characteristics, their
medical history (including comorbidities), and clinical
presentation (signs, symptoms, laboratory investigations).
These clinical data were obtained as part of the routine
clinical practice of the hospital and not specifically for
this study. All data were de-identified to ensure confi-
dentiality and subsequent checks have been performed to
ensure accuracy of the data andminimize data entry error.
Ethical approval for this cohort and study was obtained
from the KuwaitMinistry of Health’s Ethical Review Com-
mittee (ERC) (No. 2020/1402) and the LHSTM Ethical
Committee (No 22676).
Outcomes
The patients could enter the ICU, get discharged from the
hospital, transferred to a different healthcare unit, or die.
Patients are assessed by the rapid response team based
on the presence of 3 out of 7 of the following criteria:
• Age greater than 60 years;
• Heart rate greater than 100 beats per minute;
• Systolic blood pressure lower than 90mmHg or Mean
arterial pressure lower than 65mmHg;
• Temperature greater than 38.1 C;
• Respiratory Rate greater than 26 breaths per minute;
• Saturation lower than 92% on arterial blood gas or any
saturation while the patient on supplemental oxygen;
• Any pulmonary infiltrates not considered chronic
changes (chronic obstructive pulmonary disease
including emphysema, any interstitial or fibrotic lung
disease)
and are admitted to ICU if they are deemed likely to
require ventilatory or hemodynamic support. Patients
with a significant past medical history (hypertension, dia-
betes, ischemic heart disease, chronic renal failure, the
immunocompromised or any other comorbidity) are con-
sidered of higher risk patients and may have a lower
threshold for ICU admission.
We considered two competing events of interest, ICU
admission and hospital discharge (including those who
were transferred to a different care unit), on the basis
of “whichever event occurred first”. Individuals who had
not experienced any of those events were regarded as
censored. We defined two quantities, the event-specific
hazard and the cumulative probability of experiencing one
of these events as a function of time since admission in
Jaber Hospital due to COVID-19.
Statistical analysis
We estimated the event-specific hazards using flexible
hazard regression models [12] separately for ICU admis-
sion and discharge and further combined these results
in order to estimate the event-specific probabilities of
each event. The splines embedded in the flexible mod-
els are used for modelling the baseline hazard function
and potential non-linear and time-varying associations
between the outcome and the covariables. With these
models we are also able to estimate the cumulative prob-
abilities not only at population or group level, but also
at individual (i.e., covariate-specific) level according to
patient characteristics at hospital admission (i.e. age, gen-
der, comorbidities).
Some socio-demographic and clinical characteristics
were retained a priori in the analysis after the guide-
lines from the European Centre for Disease Prevention
and Control and other recent findings. They included
gender, age at admission, and the presence of various
comorbidities at admission. To avoid small numbers of
cases within strata, some of these comorbidities were
logically grouped together, namely, cardiovascular dis-
eases (CVD) with hypertension (HT), severe asthma with
chronic obstructive pulmonary disease (COPD), and can-
cer with immunodeficiency and immunosuppression to
represent those with weakened immune system. We also
included diabetes mellitus (DM) and chronic kidney dis-
ease (CKD), as well as accounted for a combination of
comorbidities gathering conditions that were not cov-
ered previously, namely dyslipidemia, hepatitis, hypothy-
roidism, and recent surgery (during the past 30 days) to
which we refer here as ‘other’. All variables were binary
except the continuous variable age. BMI and smoking sta-
tus were not considered because of their high proportion
of missing values. The rest of the variables used in this
analysis had no missing values.
A new health policy was introduced by the Ministry of
Health as of 12 May 2020 in Kuwait, instructing that the
hospital should operate only as a treatment facility hence,
limiting the hospital admission only to severe cases (i.e.,
high-risk patients or those with pneumonia). To account
for the new policy, the models included, in addition to the
a priori covariables, a binary variable describing the date
of hospital admission split into two time windows (before
or after the 12th May of 2020).
Additionally, we examined the need for interactions
between age and other covariables to account for the pos-
sibility that an association between the rest of the covari-
ables and the outcome varies with age. We run several
models and chose the final based on the Bayesian Infor-
mation Criterion which is a simple and reliable model
selection approach for descriptive purposes [13]. The per-
formance of the final models was assessed with a graph
where population non-parametric estimated probabilities
were plotted against their model-based equivalents (see
Section 3 of Appendix).
The final model for the ICU admission included the fol-
lowing covariables: age, gender, hospital admission period,
DM, CKD, CVD/HT, asthma/COPD, weakened immune
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system and ‘other’ comorbidities. Conversely, the final
model related to hospital discharge considered addition-
ally to the aforementioned covariables, an interaction
between age and gender. In both, age was modelled with a
quadratic spline with one knot at 41 years and the baseline
hazard was specified with a cubic B-spline with one knot
located close to their median time-to-event.
Lastly, we combined the results from the two event-
specific models in order to estimate the cumulative
probabilities of ICU admission and hospital discharge
[14]. We plotted the probabilities of each event accord-
ing to various covariable patterns in order to explore
the impact of each covariable on the event-specific
risk along the time since hospital admission. We also
built a user-friendly web-based tool which enables for
instance a clinician who would like to display such prob-
abilities (all derived from the parameters of the final
models) for various combinations of factors of interest
https://icon.lshtm.ac.uk/cumulative-probabilities/.
Additional technical details on themethod used to com-
pute these results can be found in the Appendix (see
Section 1). As a sensitivity analysis, we also repeated all
the analyses using Cox models instead of flexible haz-
ard models. Since the event-specific hazard ratios were
very similar, only those derived from the flexible mod-
els were presented. We also conducted a further analysis
separately on Kuwaiti and non-Kuwaiti to briefly examine
how cohort effects vary with nationality (see Section 4 of
Appendix). Lastly, we also conducted a sensitivity analy-
sis to check if the inclusion of the 6 dead people to the
censoring group are affecting the results. All data man-




Table 1 describes the baseline characteristics of the whole
cohort used for the analysis (including censored observa-
tions), separately for each event of interest.
The hospital encompasses a diverse patient population
concerning demographic characteristics and clinical pre-
sentations. During a follow-up period of up to 124 days,
3995 individuals were admitted to the hospital between 24
February to 27 May in 2020, out of which 315 (8%) had to
be treated in the ICU and 3619 (90.5%) were able to exit
the hospital facility or be transferred to a different health
care unit without previously entering the ICU. Among the
remainder (1.5%), 55 were still hospitalized outside ICU
(with or without treatment) and 6 died before entering the
ICU.
Those entering the ICU were mostly between 40 and 69
years, 84% males, 69% being non-Kuwaiti. In comparison,
the discharge group was slightly younger, with 69% males
and 58% non-Kuwaiti. Over 40% of the ICU group had
hypertension and diabetes, which were observed in 17%
of the discharge group. Information on BMI and smoking
status was missing in about 43% of the cohort. The pro-
portion of BMI at 25 and over was still the majority in
the ICU group, as was the proportion of non-smokers in
both groups. The comorbidity burden was generally lower
in the discharge group. In both groups, the majority of
admission occurred in the first time window between 24
Feb 2020 and 11 May 2020, accounting for 63% of ICU
admissions and 83% of hospital discharges.
Description of events
The majority of the ICU admissions occurred in the first
days following hospital admission, with almost 90% hap-
pening within 5 days, whereas half of the discharges took
place in the first 10 days post hospital admission. The
timing of events was also reflected on the event-specific
population cumulative probabilities for ICU admission
(CPrICU(t)) and hospital discharge (CPrDis(t)) through
different times since hospital admission (see Section 2 of
Appendix). CPrICU(t) was already 4.6% (95%C.I.: [4,5.3])
on admission day, gradually moving to 7.1% (95%C.I.:
[6.4,8]) within 5 days, and reaching a plateau at 7.9%
(95%C.I.: [7.1,8.8]) a few days later. As low as 2.7%
(95%C.I.: [2.2,3.2]) on admission day, CPrDis(t) rapidly
progressed to 48.6% (95%C.I.: [47,50]) within 10 days after
hospital admission reaching finally a maximum at 92%
(95%C.I.: [91,93]) within 30 days after hospital admission.
Results derived from themodels
Event-specific hazards Figure 1 displays the event-
specific hazard ratios of ICU admission and hospital dis-
charge associated with selected key factors of interest. Fol-
lowing the authority instruction, only patients with severe
forms of COVID-19 were admitted to Jaber Hospital from
the 12th of May 2020 onwards, as clearly indicated by
their hazard of being transferred to ICU which was mul-
tiplied by 2.7 in comparison to patients in the first period
after adjusting on other covariates. This may have not
reflected yet in lower hazard of discharge because of the
short follow-up of the second-period patients. Younger
patients experienced a lower hazard of entering the ICU
compared to their older peers, after adjusting on gender,
time of admission and comorbidities (Fig. 2-upper panel).
The peak was reached at age around 70 with a hazard
ratio equal to 3.3. The decrease of the ICU-specific HR
for patients older than 80 should be interpreted with cau-
tion given the small number of patients observed in these
age group (see Table 1). The hazard of ICU admission
was 70% lower for females than for males. The picture
was slightly more complex for hospital discharge as the
age-related hazards varied by gender (Fig. 2-lower panel).
Among women, the overall pattern showed a smooth
decrease in the discharge-specific hazard with increasing
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Table 1 Cohort description of patient characteristics at hospital admission, by event type
Number of Number of Number of
individuals individuals who individuals who
(column%) entered the ICU got discharged
(column%) (column%)
Total 3995 (100) 315 (8∗) 3619 (90.5∗)
Age group, years 0-17 291 (7.28) 2 (0.63) 288 (7.96)
18-39 1648 (41.25) 26 (8.25) 1600 (44.21)
40-49 809 (20.25) 75 (23.81) 721 (19.92)
50-59 652 (16.32) 92 (29.21) 548 (15.14)
60-69 418 (10.46) 75 (23.81) 333 (9.2)
70-79 140 (3.5) 36 (11.43) 101 (2.79)
80+ 37 (0.93) 9 (2.86) 28 (0.77)
Gender Male 2814 (70.44) 265 (84.13) 2500 (69.08)
Female 1181 (29.56) 50 (15.87) 1119 (30.92)
BMI <18.5 92 (2.3) 1 (0.32) 90 (2.49)
18.5-24.9 688 (17.22) 35 (11.11) 642 (17.74)
25-29.9 836 (20.93) 63 (20) 757 (20.92)
30-34.9 (obese class I) 402 (10.06) 44 (13.97) 354 (9.78)
35-39.9 (obese class II) 159 (3.98) 19 (6.03) 138 (3.81)
≥40 (obese class III) 81 (2.03) 9 (2.86) 72 (1.99)
Missing 1737 (43.48) 144 (45.71) 1566 (43.27)
Smoker No 2129 (53.29) 157 (49.84) 1927 (53.25)
Yes 140 (3.5) 8 (2.54) 127 (3.51)
Missing 1726 (43.2) 150 (47.62) 1565 (43.24)
Nationality Non Kuwaiti 2356 (58.97) 217 (68.89) 2103 (58.11)
Kuwaiti 1639 (41.03) 98 (31.11) 1516 (41.89)
Hypertension 778 (19.47) 138 (43.81) 628 (17.35)
Diabetes 730 (18.27) 130 (41.27) 591 (16.33)
CVD 194 (4.86) 54 (17.14) 134 (3.7)
CKD 72 (1.8) 20 (6.35) 49 (1.35)
COPD 17 (0.43) 4 (1.27) 12 (0.33)
Cancer 56 (1.4) 9 (2.86) 44 (1.22)
Asthma 235 (5.88) 31 (9.84) 200 (5.53)
Immunodeficiency 11 (0.28) 2 (0.63) 8 (0.22)
Immunosuppression 14 (0.35) 4 (1.27) 10 (0.28)
Admission date 24/02/20 to 11/05/20 3243 (81.18) 199 (63.17) 2998 (82.84)
12/05/20 to 27/05/20 752 (18.82) 116 (36.83) 621 (17.16)
Characteristics of censored individuals are not reported separately but included in the total
*row percentage (%); 1.5% are censored
age, with a hazard ratio stable around 1 between 30 and 50
years of age. By contrast, such a pattern was not observed
among males where the youngest male patients (less
than 20 years old) experienced a lower discharge-specific
hazard in comparison to middle-aged male patients.
The remaining event-specific hazards were generally
consistent with higher hazards of ICU associated
with lower hazards of discharge (Fig. 1). Presence
of asthma/COPD and CKD increased significantly
the ICU-specific hazard, with corresponding lower
discharge-specific hazards (though not significant for
asthma/COPD). Discharge-specific hazards were also
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Fig. 1 ICU-specific (left) and discharge-specific (right) hazard ratios with 95% confidence intervals. Asthma/COPD: asthma or chronic obstructive
pulmonary disease, CKD: chronic kidney disease, CVD/HT: cardiovascular diseases or hypertension, DM: diabetes mellitus
significantly lower in the presence of DM and weakened
immune system, with higher but non-significant ICU-
specific hazards.
Event-specific cumulative probabilities From this
section onwards, we will refer to cumulative probabilities
simply as probabilities for convenience.
Figures 3 and 4 show the gender-specific probabilities
(i) of ICU admission and (ii) hospital discharge accord-
ing to age and various comorbid conditions. Probabilities
are computed and displayed at different times since hos-
pital admission for each event. Results were illustrated for
the period after 12 May 2020 using the flexible regres-
sion models described in the Methods section whereas
the equivalent for the previous period can be found in
Section 5 of Appendix. Probabilities presented in both Fig
3 and 4 account for the existence of a single comorbid-
ity at a time. Our models however enable the estimation
of these probabilities for any combinations of age, gen-
der, time period and comorbid conditions. To display
such probabilities (all derived from the parameters of
the final models) for various combinations of factors of
interest we refer the reader to our web tool found at
https://icon.lshtm.ac.uk/cumulative-probabilities/.
Probabilities of ICU admission The probability of ICU
admission varied dramatically by age, following a similar
pattern in both females and males, and across the vari-
ous comorbidities, was higher in men and increased with
some comorbidities (Fig. 3). Overall, ICU-risk increased
with age and was highest at around age 70. Among indi-
viduals with none of the comorbidities, the probability to
enter the ICU went as high as 9% for females and 27%
for males only 1 day post hospital admission. Within 5
days, these probabilities increased to 11% and 30% before
stabilising in 10 days at 11% and 31% for females and
males, respectively. The presence of any of the comorbidi-
ties studied reinforced the risk of ICU admission with the
most remarkable increase noticed in the case of CKD, fol-
lowed by asthma/COPD and weakened immune system.
For instance, within 5 days a 50 year old male had 19%
(95% C.I.: [15,23]) probability of entering the ICU if he
had none of these comorbidities, yet this risk jumped to
31% (95% C.I.: [20,46]) if he had also CKD, and to 27%
in the presence of asthma/COPD (95% C.I.: [19,36]) or of
weakened immune system (95% C.I.: [16,42]). The gen-
der gap was so large that these probabilities were still
higher than those of a female 72 old within 10 days after
admission, with or without comorbidity. Lastly, whilst
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Fig. 2 ICU-specific (upper panel) and discharge- and gender-specific (lower panel) hazard ratios (HRs) with 95% confidence intervals for age at
admission. HRs are adjusted for the other covariates and reference age is 41
Fig. 3 Cumulative probability of ICU admission according to baseline characteristics (age, gender and existence of comorbidities) for females (upper
row) and males (lower row) predicted within 1, 5 and 10 days post hospital admission. Comorbidities include: chronic kidney disease (CKD),
cardiovascular diseases (CVD) or hypertension (HT), asthma or chronic obstructive pulmonary disease (COPD), weakened immune system and other
comorbidities such as dyslipidemia, hepatitis, hypothiroidism, recent surgery (during the past 30 days) etc
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Fig. 4 Cumulative probability of hospital discharge according to baseline characteristics (age, gender and existence of comorbidities) for females
(upper row) and males (lower row) predicted within 10, 20 and 30 days post hospital admission. Comorbidities include: chronic kidney disease
(CKD), cardiovascular diseases (CVD) or hypertension (HT), asthma or chronic obstructive pulmonary disease (COPD), weakened immune system and
other comorbidities such as dyslipidemia, hepatitis, hypothiroidism, recent surgery (during the past 30 days) etc
the time-varying probabilities of ICU admission for the
individuals with DM were clearly higher than those of
individuals with none of the comorbidities, presence of
CVD/HT or the comorbidities categorised as ‘other’ was
marginally associated with an increase in the probability
of being admitted to the ICU for both males and females
at all ages.
Probabilities of hospital discharge The probabilities
of discharge differed considerably between females and
males (Fig. 4). With respect to age, there is an almost
monotonic decrease in female probabilities (irrespective
of the time since hospital admission) which is not true
for males whose pattern is more complex. More specifi-
cally, probabilities increased in males at all times until 25
and later decreased until 75. This was followed by a sub-
sequent increase which was only minimal within 10 days,
more profound within 20 days and quite steep within 30
days. Although this is not always the case for previous
times, in 30 days females did much better than males at all
ages regardless of their comorbidity status.
Nevertheless, despite the obvious differences, some sim-
ilar patterns between females and males do exist. Indi-
viduals with CKD had the lowest probability of discharge
irrespective of age and time since admission, followed
by those with weakened immune system. Conversely, the
probability of discharge among patients with CVD/HT
or ‘other’ comorbidities was similar to that of patients
with none of the comorbidities. Presence of comorbidi-
ties impacted the event-specific probabilities of all ages
within 10 or 20 days post hospital admission yet this
effect was only minimal in younger individuals after
30 days.
Discussion
As additional waves of the COVID-19 pandemic are likely
to occur before a large-enough vaccination coverage of
the populations is reached, quantitative epidemiological
indicators are increasingly needed to provide a clearer pic-
ture of the disease progression and to describe how these
indicators vary according to the main patient baseline
characteristics. A detailed description of the cumulative
probabilities/risks of (i) Intensive Care Unit (ICU) admis-
sion and (ii) hospital discharge, according to prognostic
factors already identified (e.g. age, comorbidities etc.), is
of great value to improve the management of the burden
that the pandemic waves cause on the healthcare systems
and societies. Such indicators are even more crucial in
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middle-east region where this epidemiological evidence is
lacking.
Our study suggests that being male, increasing age
and the comorbidities CKD, asthma/COPD and weak-
ened immune system increased the risk of ICU admission
within the first 10 days after hospital admission. Equally,
CKD and weakened immune system decreased consider-
ably the probabilities of discharge in both genders. Yet
with respect to age, conclusions widely varied between
females and males. Probabilities in females were deteri-
orating steadily with age whereas probabilities for males
were progressing in a non-monotonic fashion, allowing
for both increase/decrease with age. In both events of
ICU and discharge, DM had only a moderate impact
on both probabilities despite being the most prevalent
comorbid condition (18% overall) in contrast to CKD
which had the largest effect, but presented only in 7%
of those admitted to ICU and in 1% of those who got
discharged.
The strengths of our study are mostly attributed to
its analytical approach. The estimation of the probabili-
ties of ICU admission and hospital discharge accounted
for their temporal component, i.e. the time since hospi-
tal admission. We also used flexible event-specific hazard
regression models which allow non-linear functions to be
modelled and the events to be analysed separately. The
selection of key demographic and clinical characteristics
(including a range of comorbidities) was made a priori.
Furthermore, the different sensitivity analyses performed
to assess some assumptions did not modify the study
conclusions. Yet, the study could be extended further to
accommodate more states into its design including the
transition between ICU and discharge or adding death
as an additional event. Analysing the complete pathway
would provide a clearer guidance on the COVID-19 treat-
ment needs and practices. However, only six individuals
in this cohort died prior to ICU/discharge hence, mod-
elling those separately was not an option and they were
censored. Excluding those six from the analysis hardly
modified the results. Lastly, two potential risk factors (i.e.
BMI and smoking) could not be considered due to the
large amount of missing data. Overcoming these issues
and including them in the analysis by applying appropriate
methodologies for missing data will be also part of future
work.
Our results are based on a single centre, which could
affect their generalisability, but it is also worth highlight-
ing the great homogeneity in data collection and that
Jaber Hospital captured the vast majority of COVID-19
patients in Kuwait at that time, regardless of the severity
of the disease. Therefore, unlike many studies in hos-
pital settings this one also included asymptomatic cases
for its most part, which reduces the risk of collider
bias because of conditioning on admission [15]. These,
combined with the analytical components, may explain
some of the differences between the literature and our
results.
Most studies in the Middle East region focused on risk
factors of mortality [16–19] among COVID-19 patients
and, to our knowledge, very little (including a few papers
from subsequent parts of the Jaber Hospital cohort) has
been published on factors associated with the risk of ICU
admission. More globally, an international meta-analysis
showed that higher mortality was strongly associated with
increasing age, male gender and the presence of obesity,
HT, DM, CVD, and cancer, and with some excess mortal-
ity associated with several other comorbidities [20]. Other
studies in the Middle East examined the risk of disease
severity or of severe complications. In addition to increas-
ing age and male gender, these studies identified as risk
factors, CKD [21, 22] and cancer [21], but also DM and/or
obesity [10, 21–23], HT and/or CHD/CVD [21–23]. Two
studies in Qatar and Kuwait, specifically focusing on ICU
admission, stressed the increased risk associated with DM
[24], in contrast with our results, findings in the literature
are quite heterogeneous. Actually, meta-analyses found
that DM was associated with higher risk of composite
event combining ICU admission with mortality and/or
severe/critical form of the disease [25–27], while other
meta-analyses found an absence of increased ICU risk
[28, 29] or the evidence inconclusive [30]. Furthermore,
to our knowledge, most studies did not account for the
time component in their analysis and none used a flexible
model.
Our stratified analysis reinforces the evidence about dif-
ferences in COVID-19 outcomes between nationals and
non-nationals in Kuwait [31] (please see Section 4 in the
Appendix). These differences may be attributed to dis-
parities in the socio-economic status between resident
citizens and migrant workers, an observation which has
also been noted in other populations with large migrant
worker population [32–34]. Migrant workers in the Gulf
countries are also predominantly of South Asian descent,
as opposed to the citizen resident populations, which
are largely of Middle Eastern origin [35]. Large prospec-
tive cohort studies [36, 37] found that ethnic minorities
with COVID-19 were more likely to be admitted to crit-
ical care, particularly South Asians who had a higher
mortality rate, compared to other ethnicities. Evidence
about the role played by genetic variation remains weak
[38]. Our models however revealed a much stronger
cohort effect on non-Kuwaiti with respect to ICU admis-
sion either due to many poor prognosis cases after 12th
May or many asymptomatic cases before 12th May com-
pared to Kuwaiti. Higher hazards of ICU admission were
observed in non-Kuwaiti with asthma/COPD and CKD
and in Kuwaiti with CVD/HT and weakened immune
system.
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In conclusion, the results of this study provided use-
ful insight in describing the probability of ICU admis-
sion and hospital discharge according to age, gender and
comorbidities of confirmed COVID-19 cases in Kuwait.
The probabilities provided a deeper understanding of this
demand according to someone’s characteristics which is
essential to hospital management. Notably, the design
of the study allowed for the estimation of ‘real-world
probabilities’ [39] avoiding hypothetical scenarios and
convoluted interpretations [40]. Further work is needed
to build predictive models which will help to improve
the management of the COVID-19 pandemic and the
patients.
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